# Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

> **NCT06531681** · — · RECRUITING · sponsor: **The Second Affiliated Hospital of Hainan Medical University** · enrollment: 3000 (estimated)

## Conditions studied

- Overall Response Rate
- Oncology
- Radiation Toxicity
- Quality of Life

## Interventions

- **DEVICE:** MR-Linac

## Key facts

- **NCT ID:** NCT06531681
- **Lead sponsor:** The Second Affiliated Hospital of Hainan Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-19
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06531681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06531681, "Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06531681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*